Welcome to our dedicated page for Nrg Energy SEC filings (Ticker: NRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how shifting fuel prices, hedge positions, and environmental liabilities affect NRG Energy can feel like decoding a maze of footnotes. Each quarter the company files dozens of pages covering power-plant performance, retail customer churn, and emissions targets—details investors can’t afford to miss.
Stock Titan turns that complexity into clarity. Our AI delivers NRG Energy SEC filings explained simply by highlighting what moves cash flows and carbon metrics. Need to spot NRG Energy insider trading Form 4 transactions or receive NRG Energy Form 4 insider transactions real-time? We surface them seconds after EDGAR posts. Curious where revenue shifted by region? The platform links the NRG Energy quarterly earnings report 10-Q filing to concise margin breakdowns and hedging updates. Other essentials are one click away:
- NRG Energy annual report 10-K simplified with AI-powered summaries of generation capacity, debt covenants, and environmental reserves
- NRG Energy proxy statement executive compensation mapped to performance metrics
- NRG Energy 8-K material events explained for plant outages, acquisitions, or credit actions
Whether you’re understanding NRG Energy SEC documents with AI for emissions analysis or comparing quarters through NRG Energy earnings report filing analysis, Stock Titan delivers every form�10-K, 10-Q, 8-K, Form 4—along with real-time alerts and plain-English takeaways. Monitor NRG Energy executive stock transactions Form 4, evaluate segment profitability, and see how regulatory changes ripple through cash flows without wading through hundreds of pages. Save research hours and make informed energy-sector decisions faster.
enVVeno Medical (NVNO) remains pre-revenue but is progressing its venous-valve pipeline while absorbing higher operating costs. In Q2-25 the company reported a net loss of $6.7 m (-0.33/sh), 35 % wider than Q2-24, driven by a 58 % jump in SG&A to $4.2 m (severance, stock comp and a $0.6 m reserve for prepaid clinical costs). R&D spend held essentially flat at $2.9 m.
Cash, cash equivalents and short-term Treasuries fell to $35.1 m from $43.2 m at YE-24; operating cash burn was $7.7 m for the first half. Working capital totals $32.6 m and management believes liquidity is adequate for �12 months, but it forecasts quarterly burn to rise to $5-7 m as trials advance.
- Pipeline: VenoValve PMA filing completed Nov-24 and is under FDA breakthrough-priority review; decision expected 2H-25.
- Interim two-year data (n=42) show 83 % of pivotal-trial patients retain �3-point rVCSS improvement, 74 % median pain reduction and 100 % valve patency (n=30).
- enVVe transcatheter valve finished GLP study; IDE submission targeted Q3-25.
- 19.2 m shares outstanding after exercising 1.7 m pre-funded warrants.
Key takeaways: Clinical results and regulatory momentum are constructive, but losses, cash draw and the absence of revenue keep financing risk on the table.
On 14 Jul 2025, HA Sustainable Infrastructure Capital, Inc. (HASI) filed an 8-K announcing the appointment of Nitya Gopalakrishnan, 53, as Executive Vice President & Chief Operating Officer.
Gopalakrishnan joins from BlackRock, where she most recently served as Managing Director & Head of Investment Infrastructure, SMA Solutions, following 25 years in senior platform, engineering and COO roles. The filing states there are no related-party relationships or transactions requiring disclosure.
The offer letter sets a $400 k base salary, target annual cash bonus equal to 125 % of salary, and a 20,000-share restricted-stock sign-on grant vesting over three years. She is also eligible for annual LTIP awards (~100 % of salary) and up to $100 k relocation reimbursement.
If terminated without cause, severance includes 12-months salary, an average prior-bonus payout, one year of health benefits, and full acceleration of all unvested equity.
No other material events, financial results, or transactions were disclosed.